Diagnostic antibodies and antigens for Liver Diseases testing: Hyaluronic acid (HA), laminins (LN), collagen type IV (cIV), Procollagen III N-terminal peptide (PIIINP), Lithocholic Acid (LCA), deoxycholic acid (cholanoic acid), hyaluronic acid (HA), Cholyglycine (CG), Prealbumin (PA), Antipyrine (AP), Barbital (BAR)


Liver is an important organ and it is responsible for the metabolism, energy storage, and waste filtering. Liver disease is a generally designates to any condition that affects the liver. These conditions may be because of different reasons, but all these reasons damage the liver and affect its function. Many people with liver disease do not cause any symptoms in the early stages. At a certain point in the development of liver disease damage can become irreversible and lead to liver failure, liver cancer, or death. Early diagnosis of liver disease may prevent liver damage. GENEMEDI produces core diagnostic ingredients such as collagen type IV, Procollagen III N-terminal peptide, Lithocholic Acid, deoxycholic acid, hyaluronic acid, Cholyglycine, Prealbumin and so on for test of Liver Diseases and related syndrome using ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT Kit.

Classification: HABP LN cIV PIIINP LCA cholanoic acid HA CG PA AP BAR



Hyaluronic acid binding protein (HABP)

Cat No. Species Biomarker Disease Cat No.of Antigen Bioactivity validation of Antigen Cat No.of Antibodies Bioactivity validation of Antibodies Order
GMP-h-HABP Human Hyaluronic acid binding protein (HABP) rheumatoid arthritis (RA) andosteoarthritis GMP-h-HABP-Ag01:
Hyaluronic acid binding protein (HABP)
Hyaluronic acid (HA) Antibody Binding, Immunogen in Sandwich ELISA test, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT. GMP-h-HABP-Ab01;
GMP-h-HABP-Ab02:
Anti-Hyaluronic acid binding protein (HABP) mouse monoclonal antibody(mAb)
Human Hyaluronic acid (HA) protein binding, ELISA validated as capture antibody and detection antibody. Pair in HAlevel test and Liver Diseases/Fibrosis evaluation. Picture loading failed.



laminins (LN)

Cat No. Species Biomarker Disease Cat No.of Antigen Bioactivity validation of Antigen Cat No.of Antibodies Bioactivity validation of Antibodies Order
GMP-h-LN Human laminins (LN) muscular dystrophy, lethal skin blistering disease (junctional epidermolysis bullosa) and nephrotic syndrome GMP-h-LN-Ag01:
Recombinant human LN Protein
laminins (LN) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in LN level test of Liver diseases(muscular dystrophy, lethal skin blistering disease (junctional epidermolysis bullosa) and nephrotic syndrome) and related syndrome evaluation. GMP-h-LN-Ab01;
GMP-h-LN-Ab02:
Anti-human LN mouse monoclonal antibody(mAb)
Human laminins (LN) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other laminins (LN) antibodies in LN level test of Liver diseases (muscular dystrophy, lethal skin blistering disease (junctional epidermolysis bullosa) and nephrotic syndrome) and related syndrome evaluation. Picture loading failed.



collagen type IV (cIV)

Cat No. Species Biomarker Disease Cat No.of Antigen Bioactivity validation of Antigen Cat No.of Antibodies Bioactivity validation of Antibodies Order
GMP-h-cIV Human collagen type IV (cIV) Goodpasture syndrome, Alport syndrome, glomerular basement membrane, Liver fibrosis and cirrhosis, alcoholic liver disease, hepatitis C and fall following successful therapy. autosomal dominant hereditary angiopathy, nephropathy, aneurysms, and muscle cramps. porencephaly, schizencephaly, congenital cataract, coronary artery disease, diabetic nephropathy and renal injury. GMP-h-cIV-Ag01:
Recombinant human cIV Protein
collagen type IV (cIV) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in cIV level test of Liver diseases(Goodpasture syndrome, Alport syndrome, glomerular basement membrane, Liver fibrosis and cirrhosis, alcoholic liver disease, hepatitis C and fall following successful therapy. autosomal dominant hereditary angiopathy, nephropathy, aneurysms, and muscle cramps. porencephaly, schizencephaly, congenital cataract, coronary artery disease, diabetic nephropathy and renal injury.) and related syndrome evaluation. GMP-h-cIV-Ab01;
GMP-h-cIV-Ab02:
Anti-human cIV mouse monoclonal antibody(mAb)
Human collagen type IV (cIV) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other collagen type IV (cIV) antibodies in cIV level test of Liver diseases (Goodpasture syndrome, Alport syndrome, glomerular basement membrane, Liver fibrosis and cirrhosis, alcoholic liver disease, hepatitis C and fall following successful therapy. autosomal dominant hereditary angiopathy, nephropathy, aneurysms, and muscle cramps. porencephaly, schizencephaly, congenital cataract, coronary artery disease, diabetic nephropathy and renal injury.) and related syndrome evaluation. Picture loading failed.



Procollagen III N-terminal peptide (PIIINP)

Cat No. Species Biomarker Disease Cat No.of Antigen Bioactivity validation of Antigen Cat No.of Antibodies Bioactivity validation of Antibodies Order
GMP-h-PIIINP Human Procollagen III N-terminal peptide (PIIINP) liver fibrosis and cirrhosis GMP-h-PIIINP-Ag01:
Recombinant human PIIINP Protein
Procollagen III N-terminal peptide (PIIINP) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in PIIINP level test of Liver diseases(liver fibrosis and cirrhosis) and related syndrome evaluation. GMP-h-PIIINP-Ab01;
GMP-h-PIIINP-Ab02:
Anti-human PIIINP mouse monoclonal antibody(mAb)
Human Procollagen III N-terminal peptide (PIIINP) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Procollagen III N-terminal peptide (PIIINP) antibodies in PIIINP level test of Liver diseases (liver fibrosis and cirrhosis) and related syndrome evaluation. Picture loading failed.



Lithocholic Acid (LCA)

Cat No. Species Biomarker Disease Cat No.of Antigen Bioactivity validation of Antigen Cat No.of Antibodies Bioactivity validation of Antibodies Order
GMP-SMT-LCA Human Lithocholic Acid (LCA) liver damage GMP-SMT-LCA-Ag01:
BSA-Lithocholic Acid (LCA);
GMP-SMT-LCA-Ag02:
OVA-Lithocholic Acid (LCA)
Competitive immunoassay-validated hapten-carrier conjugates [BSA-&OVA-Lithocholic Acid (LCA)], Lithocholic Acid (LCA) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in LCA level test of Liver diseases (liver damage) and related syndrome evaluation. GMP-SMT-LCA-Ab01:
Anti-Lithocholic Acid (LCA) mouse monoclonal antibody(mAb)
Human Lithocholic Acid (LCA) binding, in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays in LCA level test of Liver diseases (liver damage) and related syndrome evaluation. Picture loading failed.



deoxycholic acid (cholanoic acid)

Cat No. Species Biomarker Disease Cat No.of Antigen Bioactivity validation of Antigen Cat No.of Antibodies Bioactivity validation of Antibodies Order
GMP-SMT-cholanoic-acid Human deoxycholic acid (cholanoic acid) liver cirrhosis, chronic kidney disease, vascular calcification, vasculature toxicity GMP-SMT-cholanoic-acid-Ag01:
BSA-deoxycholic acid (cholanoic acid);
GMP-SMT-cholanoic-acid-Ag02:
OVA-deoxycholic acid (cholanoic acid)
Competitive immunoassay-validated hapten-carrier conjugates [BSA-&OVA-deoxycholic acid (cholanoic acid)], deoxycholic acid (cholanoic acid) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in cholanoic acid level test of Liver diseases (liver cirrhosis, chronic kidney disease, vascular calcification, vasculature toxicity) and related syndrome evaluation. GMP-SMT-cholanoic-acid-Ab01:
Anti-deoxycholic acid (cholanoic acid) mouse monoclonal antibody(mAb)
Human deoxycholic acid (cholanoic acid) binding, in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays in cholanoic acid level test of Liver diseases (liver cirrhosis, chronic kidney disease, vascular calcification, vasculature toxicity) and related syndrome evaluation. Picture loading failed.



hyaluronic acid (HA)

Cat No. Species Biomarker Disease Cat No.of Antigen Bioactivity validation of Antigen Cat No.of Antibodies Bioactivity validation of Antibodies Order
GMP-SMT-HA Human hyaluronic acid (HA) GMP-SMT-HA-Ag01:
BSA-hyaluronic acid (HA);
GMP-SMT-HA-Ag02:
OVA-hyaluronic acid (HA)
Competitive immunoassay-validated hapten-carrier conjugates [BSA-&OVA-hyaluronic acid (HA)], hyaluronic acid (HA) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in HA level test of Liver diseases and related syndrome evaluation. GMP-SMT-HA-Ab01:
Anti-hyaluronic acid (HA) mouse monoclonal antibody(mAb)
Human hyaluronic acid (HA) binding, in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays in HA level test of Liver diseases and related syndrome evaluation. Picture loading failed.



Cholyglycine (CG)

Cat No. Species Biomarker Disease Cat No.of Antigen Bioactivity validation of Antigen Cat No.of Antibodies Bioactivity validation of Antibodies Order
GMP-SMT-CG Human Cholyglycine (CG) liver cirrhosis or obstructive liver disease GMP-SMT-CG-Ag01:
BSA-Cholyglycine (CG)
GMP-SMT-CG-Ag02:
OVA-Cholyglycine (CG)
Competitive immunoassay-validated hapten-carrier conjugates [BSA-&OVA-Cholyglycine (CG)], Cholyglycine (CG) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in CG level test of Liver diseases (liver cirrhosis or obstructive liver disease) and related syndrome evaluation. GMP-SMT-CG-Ab01:
Anti-Cholyglycine (CG) mouse monoclonal antibody(mAb)
Human Cholyglycine (CG) binding, in Competitive immunoassay validation, Elisa, lateral-flow tests, and other immunoassays in CG level test of Liver diseases (liver cirrhosis or obstructive liver disease) and related syndrome evaluation. Picture loading failed.



Prealbumin (PA)

Cat No. Species Biomarker Disease Cat No.of Antigen Bioactivity validation of Antigen Cat No.of Antibodies Bioactivity validation of Antibodies Order
GMP-h-PA Human Prealbumin (PA) liver disease, inflammation, or tissue death GMP-h-PA-Ag01:
Recombinant human PA Protein
Prealbumin (PA) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests,and other immunoassays as control material in PA level test of Liver diseases(liver disease, inflammation, or tissue death) and related syndrome evaluation. GMP-h-PA-Ab01;
GMP-h-PA-Ab02:
Anti-human PA mouse monoclonal antibody(mAb)
Human Prealbumin (PA) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Prealbumin (PA) antibodies in PA level test of Liver diseases (liver disease, inflammation, or tissue death) and related syndrome evaluation. Picture loading failed.



Antipyrine(AP)

Cat No.SpeciesBiomarkerDiseaseCat No.of AntigenBioactivity validation of AntigenCat No.of AntibodiesBioactivity validation of AntibodiesOrder
GMP-SMT-204HumanAntipyrine(AP)GMP-SMT-204-Ag01:
BSA-Antipyrine(AP)
GMP-SMT-204-Ag02:
OVA-Antipyrine(AP)
Competitive immunoassay-validated hapten-carrier conjugates BSA-&OVA-Antipyrine(AP), Antipyrine(AP) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in AP level test of Liver diseases and related syndrome evaluation.GMP-SMT-204-Ab01:
Anti-Antipyrine(AP) mouse monoclonal antibody(mAb)
GMP-SMT-204-Ab02:
Anti-Antipyrine(AP) human monoclonal antibody(mAb)
Antipyrine(AP) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Antipyrine(AP) antibodies in AP level test of Liver diseases and related syndrome evaluation.Picture loading failed.



Barbital (BAR)

Cat No.SpeciesBiomarkerDiseaseCat No.of AntigenBioactivity validation of AntigenCat No.of AntibodiesBioactivity validation of AntibodiesOrder
GMP-SMT-224HumanBarbital (BAR)GMP-SMT-224-Ag01:
BSA-Barbital (BAR)
GMP-SMT-224-Ag02:
OVA-Barbital (BAR)
Competitive immunoassay-validated hapten-carrier conjugates BSA-&OVA-Barbital (BAR), Barbital (BAR) antibodies binding, Immunogen in Competitive immunoassay validation, Elisa, lateral-flow tests,and other immunoassays as control material in BAR level test of Liver diseases and related syndrome evaluation.GMP-SMT-224-Ab01:
Anti-Barbital (BAR) mouse monoclonal antibody(mAb)
GMP-SMT-224-Ab02:
Anti-Barbital (BAR) human monoclonal antibody(mAb)
Barbital (BAR) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Barbital (BAR) antibodies in BAR level test of Liver diseases and related syndrome evaluation.Picture loading failed.






GENEMEDI
Email: [email protected]   [email protected]
Telephone: +86-21-50478399   Fax: 86-21-50478399
Privacy Policy
<